Supernus Pharmaceuticals, Inc. (SUPN)
49.82
-0.18
(-0.36%)
USD |
NASDAQ |
Jan 20, 16:00
49.52
-0.30
(-0.60%)
After-Hours: 07:18
Supernus Pharmaceuticals Market Cap: 2.857B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amphastar Pharmaceuticals, Inc. | 1.192B |
| BridgeBio Pharma, Inc. | 14.88B |
| Catalyst Pharmaceuticals, Inc. | 2.874B |
| Assembly Biosciences, Inc. | 423.90M |
| Viking Therapeutics, Inc. | 3.789B |
Market Cap Related Metrics
| PS Ratio | 4.121 |
| Price to Book Value | 2.722 |
| Price to Free Cash Flow | 39.70 |
| Price | 49.82 |
| Earnings Yield | -0.68% |